New OptiForm® Solution Suite
Catalent has broadened the scope of its OptiForm® Solution Suite platform to provide an efficient and seamless path from late-stage discovery to phase I clinical trials.
Catalent has broadened the scope of its OptiForm® Solution Suite platform to provide an efficient and seamless path from late-stage discovery to phase I clinical trials.
The new service includes more comprehensive candidate screening tools, ADME considerations and in silico DMPK modeling, as well as additional bioavailability enhancing tools, to provide materials for cGLP toxicological studies, and on to first-in-human studies.
14 Schoolhouse Rd, Somerset, NJ 08873
tel. +1.888.SOLUTION (765.8846)
AAPS Booth #3016
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.